AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugargic MF 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Neorangic Healthcare Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Sugargic MF 2mg/500mg Tablet SR

Diabetic combination therapy, exemplified by the 2mg/500mg sustained-release tablet formulation, combats type 2 diabetes in adults. This dual-action medication effectively manages blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician, subject to adjustments based on blood sugar monitoring. Continuous use is crucial; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a holistic approach encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. To mitigate this, maintain regular mealtimes and carry a readily available fast-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions necessitate physician consultation before commencing treatment. Pregnant or lactating individuals require medical advice before use. Regular blood glucose monitoring is vital, alongside periodic blood tests to assess blood cell counts and liver function.

Uses of Sugargic MF 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sugargic MF 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sugargic MF 2mg/500mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Sugargic MF 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Sugargic MF 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugargic MF 2mg/500mg Sustained-Release tablets with food.

How Sugargic MF 2mg/500mg Tablet SR works:

Sugargic MF 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: it decreases hepatic glucose output, slows intestinal glucose uptake, and improves insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Sugargic MF 2mg/500mg Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sugargic MF 2mg/500mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Sugargic MF 2mg/500mg tablets are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sugargic MF 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Sugargic MF 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Sugargic MF 2mg/500mg Tablet SR :

Should you forget a Sugargic MF 2mg/500mg Tablet SR dose, take it promptly. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sugargic MF 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sugargic MF 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugargic MF 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sugargic MF and seek immediate medical attention.
Sugargic MF 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Sugargic MF 2mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Sugargic MF 2mg/500mg Tablet SR can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Yes, Sugargic MF 2mg/500mg SR tablets can lower blood sugar (cause hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. Hypoglycemia risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Sugargic MF 2mg/500mg Tablet SR with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Sugargic MF 2mg/500mg Tab...
64
MRP 78
17% off